Guangdong, China

Yu Xia

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Zhongshan, CN (2019 - 2024)
  • Guangdong, CN (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):

Title: The Innovative Journey of Inventor Yu Xia

Introduction

Yu Xia is a prominent inventor based in Guangdong, China, recognized for his remarkable contributions to the field of immunology. With a portfolio of 15 patents, Yu Xia has consistently demonstrated his dedication to pioneering therapeutic solutions that address critical health challenges.

Latest Patents

Among Yu Xia's most notable inventions are two groundbreaking patents:

1. **Anti-IL-1β Antibody and Pharmaceutical Composition Thereof**: This invention pertains to an anti-IL-1β antibody and its pharmaceutical applications. The antibody is designed to effectively bind to human IL-1B, blocking its interaction with the IL-1R1 receptor, thereby inhibiting downstream signaling pathways. This innovative approach holds potential for treating autoimmune diseases, including cryopyrin-associated periodic syndromes, systemic juvenile idiopathic arthritis, gouty arthritis, cardiovascular diseases, and tumors.

2. **Anti-PD-1/VEGFA Bifunctional Antibody and Pharmaceutical Composition Thereof**: This patent involves a bifunctional antibody targeting both VEGFA and PD-1. By relieving immunosuppression and inhibiting tumor-induced angiogenesis, this invention showcases Yu Xia's commitment to advancing tumor treatment methodologies.

Career Highlights

Throughout his career, Yu Xia has worked with leading pharmaceutical companies such as Akeso Biopharma, Inc. and Ad Pharmaceutical Co., Inc. His experiences in these organizations have significantly shaped his research and innovation strategies, allowing him to contribute effectively to the field of immunotherapy.

Collaborations

Yu Xia has collaborated with several talented individuals in the industry, including Baiyong Li and Zhongmin Maxwell Wang. These partnerships have facilitated the exchange of ideas and expertise, fostering a collaborative environment conducive to innovation.

Conclusion

Yu Xia's impressive track record as an inventor is marked by his commitment to improving healthcare through innovative solutions. His latest patents demonstrate his pioneering spirit and dedication to addressing the complexities of immunological disorders and cancer treatment. With ongoing contributions to the field, Yu Xia continues to inspire future innovations in biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…